{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:42:00Z","timestamp":1763534520207,"version":"3.45.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Understanding the interplay between immunogenic cell death (ICD), ferroptosis, and prostate cancer (PCa) is critical for elucidating the underlying mechanisms of PCa pathogenesis. This study aimed to establish a prognostic model for PCa based on ICD- and ferroptosis-related genes (IFRGs) and to evaluate its potential clinical applicability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>RNA sequencing data and clinical information of PCa patients were obtained from The Cancer Genome Atlas (TCGA-PRAD) database. Candidate IFRGs were identified through Pearson correlation and differential expression analyses. A prognostic model was constructed using univariate Cox regression, least absolute shrinkage and selection operator (LASSO) regression, and Kaplan\u2013Meier survival analyses, and subsequently validated in an external cohort (GSE70769). In addition, siRNA-mediated knockdown of the key gene TREX1 was performed in PC-3 cells, and EdU and Transwell assays were conducted to assess its effects on tumor cell proliferation, migration, and invasion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A three-gene IFRG-based prognostic model was developed, which effectively stratified PCa patients into high- and low-risk groups with significantly different survival outcomes. Multivariate Cox regression analysis confirmed the model as an independent prognostic factor. Functional experiments further demonstrated that TREX1 serves as a critical risk gene, and its knockdown markedly suppressed the proliferative, migratory, and invasive capacities of PCa cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The three-gene IFRG-based prognostic model may serve as a promising prognostic biomarker for PCa, providing predictive value and novel insights into the complex interactions between IFRGs and PCa progression. Moreover, TREX1 was identified as a potential therapeutic target, offering new perspectives for prognostic assessment and the development of immunotherapy strategies in PCa.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1708437","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:37:15Z","timestamp":1763534235000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a prognostic model based on immunogenic cell death\/ferroptosis-related genes and the study of TREX1 effects on prostate cancer cells"],"prefix":"10.3389","volume":"16","author":[{"given":"Yaoan","family":"Wen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyuan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangbin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoxing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","article-title":"Prostate cancer","volume":"7","author":"Rebello","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100962","article-title":"Current therapy and drug resistance in metastatic castration-resistant prostate cancer","volume":"68","author":"Cai","year":"2023","journal-title":"Drug Resist Update"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1126752","article-title":"Progression in immunotherapy for advanced prostate cancer","volume":"13","author":"Liang","year":"2023","journal-title":"Front Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11912-021-01084-0","article-title":"Prostate cancer immunotherapy-finally in from the cold","volume":"23","author":"Runcie","year":"2021","journal-title":"Curr Oncol Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and damps in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.5483\/BMBRep.2023-0024","article-title":"Immunogenic cell death in cancer immunotherapy","volume":"56","author":"Choi","year":"2023","journal-title":"BMB Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","article-title":"Immunogenic cell stress and death","volume":"23","author":"Kroemer","year":"2022","journal-title":"Nat Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e2207077","DOI":"10.1002\/smll.202207077","article-title":"Pegylated manganese-zinc ferrite nanocrystals combined with intratumoral implantation of micromagnets enabled synergetic prostate cancer therapy via ferroptotic and immunogenic cell death","volume":"19","author":"Wang","year":"2023","journal-title":"Small"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1581951","article-title":"Research progress on the cross-regulation between ferroptosis and immunogenic cell death in tumor micro-environment","volume":"15","author":"Liu","year":"2025","journal-title":"Front Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.21037\/tau-24-415","article-title":"Ferroptosis-related gene signature predicts prognosis and immune microenvironment in prostate cancer","volume":"13","author":"Wang","year":"2024","journal-title":"Transl Androl Urol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1160972","article-title":"Subtype and prognostic analysis of immunogenic cell death-related gene signature in prostate cancer","volume":"13","author":"Kang","year":"2023","journal-title":"Front Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e1069938","DOI":"10.1080\/2162402X.2015.1069938","article-title":"Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian Malignancies: A large-scale meta-analysis","volume":"5","author":"Garg","year":"2016","journal-title":"Oncoimmunology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baaa021","article-title":"Ferrdb: A manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations","volume":"2020","author":"Zhou","year":"2020","journal-title":"Database (Oxford)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq170","article-title":"Consensusclusterplus: A class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for rna-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118","article-title":"Clusterprofiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e107468","DOI":"10.1371\/journal.pone.0107468","article-title":"Prrophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels","volume":"9","author":"Geeleher","year":"2014","journal-title":"PloS One"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-024-00869-9","article-title":"Unlocking ferroptosis in prostate cancer - the road to novel therapies and imaging markers","volume":"21","author":"Cao","year":"2024","journal-title":"Nat Rev Urol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1002\/1878-0261.12851","article-title":"Targeting immunogenic cell death in cancer","volume":"14","author":"Ahmed","year":"2020","journal-title":"Mol Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16034","article-title":"Emerging roles of ferroptosis in the tumor immune landscape: from danger signals to anti-tumor immunity","volume":"289","author":"Shi","year":"2022","journal-title":"FEBS J"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1862949","article-title":"Ferroptosis becomes immunogenic: implications for anticancer treatments","volume":"10","author":"Tang","year":"2020","journal-title":"Oncoimmunology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.734407","article-title":"Transcriptomic analysis identified two subtypes of brain tumor characterized by distinct immune infiltration and prognosis","volume":"11","author":"Shen","year":"2021","journal-title":"Front Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.877896","article-title":"Immune subtypes in luad identify novel tumor microenvironment profiles with prognostic and therapeutic implications","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1012164","article-title":"Macrophage-related molecular subtypes in lung adenocarcinoma identify novel tumor microenvironment with prognostic and therapeutic implications","volume":"13","author":"Wen","year":"2022","journal-title":"Front Genet"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2550","article-title":"Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition","volume":"5","author":"Tamaki","year":"2014","journal-title":"Oncotarget"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-014-0099-0","article-title":"Targeting DNA repair with combination veliparib (Abt-888) and temozolomide in patients with metastatic castration-resistant prostate cancer","volume":"32","author":"Hussain","year":"2014","journal-title":"Invest New Drugs"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20071647","article-title":"Aicar induces apoptosis and inhibits migration and invasion in prostate cancer cells through an ampk\/mtor-dependent pathway","volume":"20","author":"Su","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/pros.20097","article-title":"Retinoic acid slows progression and promotes apoptosis of spontaneous prostate cancer","volume":"61","author":"Huss","year":"2004","journal-title":"Prostate"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M010051200","article-title":"Structure and expression of the trex1 and trex2 3' \u2013> 5' Exonuclease genes","volume":"276","author":"Mazur","year":"2001","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.28.19655","article-title":"Identification and expression of the trex1 and trex2 cdna sequences encoding mammalian 3'\u2013>5' Exonucleases","volume":"274","author":"Mazur","year":"1999","journal-title":"J Biol Chem"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2022.104527","article-title":"Trex1 plays multiple roles in human diseases","volume":"375","author":"Wang","year":"2022","journal-title":"Cell Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2022.119278","article-title":"Cytoplasmic DNA in cancer cells: several pathways that potentially limit dnase2 and trex1 activities","volume":"1869","author":"Anindya","year":"2022","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-024-03248-1","article-title":"Tissue factor promotes trex1 protein stability to evade cgas-sting innate immune response in pancreatic ductal adenocarcinoma","volume":"44","author":"Xue","year":"2025","journal-title":"Oncogene"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.CRC-24-0360","article-title":"Targeting trex1 induces innate immune response in drug-resistant small-cell lung cancer","volume":"4","author":"Murayama","year":"2024","journal-title":"Cancer Res Commun"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.660184","article-title":"Trex1 as a novel immunotherapeutic target","volume":"12","author":"Hemphill","year":"2021","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31316","article-title":"Inhibition of nox4-dependent ros signaling attenuates prostate fibroblast activation and abrogates stromal-mediated protumorigenic interactions","volume":"143","author":"Sampson","year":"2018","journal-title":"Int J Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16829","article-title":"Overexpression of nox4 predicts poor prognosis and promotes tumor progression in human colorectal cancer","volume":"8","author":"Lin","year":"2017","journal-title":"Oncotarget"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101116","article-title":"Tumoral nox4 recruits M2 tumor-associated macrophages via ros\/pi3k signaling-dependent various cytokine production to promote nsclc growth","volume":"22","author":"Zhang","year":"2019","journal-title":"Redox Biol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112052","article-title":"Nox4 regulates gastric cancer cell invasion and proliferation by increasing ferroptosis sensitivity through regulating ros","volume":"132","author":"Wang","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/odi.13540","article-title":"Overexpression of rrm2 is related to poor prognosis in oral squamous cell carcinoma","volume":"27","author":"Wang","year":"2021","journal-title":"Oral Dis"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.18632\/aging.204315","article-title":"Comprehensive bioinformatics analysis of ribonucleoside diphosphate reductase subunit M2(Rrm2) gene correlates with prognosis and tumor immunotherapy in pan-cancer","volume":"14","author":"Wu","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-4046","article-title":"A novel mechanism driving poor-prognosis prostate cancer: overexpression of the DNA repair gene, ribonucleotide reductase small subunit M2 (Rrm2)","volume":"25","author":"Mazzu","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s13578-023-01157-6","article-title":"The key cellular senescence related molecule rrm2 regulates prostate cancer progression and resistance to docetaxel treatment","volume":"13","author":"Cheng","year":"2023","journal-title":"Cell Biosci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1708437\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:37:15Z","timestamp":1763534235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1708437\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2025.1708437"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1708437","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"article-number":"1708437"}}